Here's what to expect this week on Diagnostic Imaging.
In this week’s preview, here are some highlights of what you can expect to see coming soon:
COVID-19 vaccine-related adenopathies picked up on breast imaging have garnered a great deal of attention over the past few months. In a new study published in Clinical Imaging, investigators discuss patterns identified on scans that can give providers confidence in rendering a benign assessment. Look for the article later this week.
For more COVID-19 vaccine-related adenopathies and breast imaging coverage, click here.
The use of contrast-enhanced mammography is growing, but does it work the same across all pieces of equipment? In a new study published this week, researchers point out that artifacts picked up via this type of scan show up differently on equipment produced by different vendors. Watch for the article this week.
For more contrast-enhanced mammography coverage, click here.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
Have you ever wondered if there is a way to choose the best radiology resident for your program? It turns out there are factors you should consider that will help you select the best candidates who will likely to on to have the most success. Look for an article this week that outlines what those characteristics might be.
For more coverage of radiology residency, click here.
New Collaboration Offers Promise of Automating Prior Authorizations in Radiology with AI
March 26th 2025In addition to a variety of tools to promote radiology workflow efficiencies, the integration of the Gravity AI tools into the PowerServer RIS platform may reduce time-consuming prior authorizations to minutes for completion.
AI-Initiated Recalls After Screening Mammography Demonstrate Higher PPV for Breast Cancer
March 18th 2025While recalls initiated by one of two reviewing radiologists after screening mammography were nearly 10 percent higher than recalls initiated by an AI software, the AI-initiated recalls had an 85 percent higher positive predictive value for breast cancer, according to a new study.